oleic acid has been researched along with bosentan anhydrous in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Couture, R; Da-Silva, S; Guimarães, CL; Rae, GA | 1 |
| Guimarães, CL; Rae, GA; Trentin, PG | 1 |
| Abdel Kafi, S; Bejjani, G; Biarent, D; Hubloue, I; Leeman, M; Mélot, C; Naeije, R | 1 |
4 other study(ies) available for oleic acid and bosentan anhydrous
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Mixed endothelin ET(A) and ET(B) antagonist bosentan inhibits oleic acid-induced lung plasma extravasation in mouse.
Topics: Animals; Bosentan; Capillary Permeability; Dose-Response Relationship, Drug; Endothelin Receptor Antagonists; Endothelins; Evans Blue; Male; Mice; Oleic Acid; Receptor, Endothelin A; Receptor, Endothelin B; Respiratory Distress Syndrome; Sulfonamides | 2000 |
Endothelin ET(B) receptor-mediated mechanisms involved in oleic acid-induced acute lung injury in mice.
Topics: Acute Disease; Analysis of Variance; Animals; Atrasentan; Bosentan; Bronchoalveolar Lavage Fluid; Disease Models, Animal; Dose-Response Relationship, Drug; Endothelin Receptor Antagonists; Evans Blue; Lung; Male; Mice; Mice, Inbred Strains; Neutrophil Infiltration; Oleic Acid; Pyrimidines; Pyrrolidines; Receptor, Endothelin A; Receptor, Endothelin B; Respiratory Distress Syndrome; Sulfonamides | 2002 |
Endothelin receptor blockade in canine oleic acid-induced lung injury.
Topics: Animals; Antihypertensive Agents; Bosentan; Disease Models, Animal; Dogs; Drug Evaluation, Preclinical; Endothelin Receptor Antagonists; Infusions, Intravenous; Oleic Acid; Prospective Studies; Pulmonary Circulation; Pulmonary Gas Exchange; Pulmonary Wedge Pressure; Receptor, Endothelin A; Receptor, Endothelin B; Receptors, Endothelin; Respiratory Distress Syndrome; Sulfonamides; Vascular Resistance | 2003 |